Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.75    0.00 (0.00%)
Bid:
10.50
Ask:
11.00
Spread: 0.50 (4.762%)
Market Cap: £14.94m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Interim Trading Update

24 Jul 2018 07:00

RNS Number : 5118V
Ebiquity PLC
24 July 2018
 

Ebiquity Plc

("the Company")

 

 

Interim Trading Update

 

 

Ebiquity plc, a leading independent marketing and media consultancy, today announces its interim update for the 6 months ended 30 June 2018 ("the period").

 

Whilst first half revenues from the Media (formerly Media Value Measurement) segment and Analytics & Tech (formerly Marketing Performance Optimization) segment grew 7% over the prior year on a like-for-like ("LFL") basis, uncertainty arising from the UK Competition and Markets Authority ("CMA") investigation into the planned disposal of the Intel segment to Nielsen, announced in February 2018, has impacted Intel sales with H1 2018 LFL revenues down 9% versus 2017.

 

We have accelerated the phasing of investment in the growing Media and Analytics & Tech segments (representing c78% of the business) in the first half on the back of strong new business pipelines. As a result, we already have visibility into faster (double digit) revenue growth within these segments in H2 2018. Although this accelerated investment will impact H1 operating profit, performance in these segments for the full year is anticipated to meet existing expectations.

 

In the Intel segment (representing c22% of the business), the CMA Phase 2 process is formally due to complete no later than December 2018, we therefore anticipate that uncertainty will continue to impact revenues and profits in the second half of the year.

 

Overall, the impact of the performance of the Intel segment will not be entirely offset by the strong performance from Media and Analytics & Tech and consequently the Board currently anticipates profits for the year to be less than full-year market expectations.

 

The Company will release its interim report for the 6 months ended 30 June 2018 on 25 September 2018.

24 July 2018

Enquiries:

 

Ebiquity plc

Michael Karg (CEO)

Andrew Noble (CFO)

 

020 7650 9600

 

Instinctif Partners

Matthew Smallwood

Guy Scarborough

020 7457 2020

 

Numis Securities Limited

Nick Westlake (NOMAD)

Toby Adcock (Corporate Broker)

 

020 7260 1000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLFFLLDTIVFIT
Date   Source Headline
8th Sep 20087:00 amRNSAGM Statement
29th Aug 200810:23 amRNSTotal Voting Rights
7th Aug 20081:33 pmRNSHolding(s) in Company
7th Aug 20087:00 amRNSChange of Name to Ebiquity
28th Jul 20082:05 pmRNSHolding(s) in Company
23rd Jul 20087:00 amRNSFinal Results
11th Jun 20084:00 pmRNSHolding(s) in Company
3rd Jun 20087:00 amRNSTrading Statement
7th May 20084:10 pmRNSHolding(s) in Company
25th Apr 20087:00 amRNSStrategy update
24th Apr 20087:01 amRNSBoard appointment
3rd Apr 20088:41 amRNSDirector/PDMR Shareholding
12th Mar 200810:32 amRNSHolding(s) in Company
29th Feb 200812:15 pmRNSHolding(s) in Company
22nd Feb 20081:11 pmRNSDirectorate Change
6th Feb 20083:47 pmRNSHolding(s) in Company
4th Feb 20082:07 pmRNSHolding(s) in Company
4th Feb 20082:05 pmRNSHolding(s) in Company
24th Jan 20087:01 amRNSDirector/PDMR Shareholding
23rd Jan 20087:02 amRNSInterim Results
10th Jan 200810:11 amRNSNotice of Results
7th Dec 20073:39 pmRNSHolding(s) in Company
7th Dec 20079:17 amRNSHolding(s) in Company
8th Nov 20071:14 pmRNSHolding(s) in Company
31st Oct 20072:59 pmRNSTotal Voting Rights
29th Oct 20073:07 pmRNSAdditional Listing
29th Oct 20078:56 amRNSAdditional Listing
11th Oct 200712:35 pmRNSDirector/PDMR Shareholding
2nd Oct 20074:27 pmRNSDirector/PDMR Shareholding
28th Sep 20073:51 pmRNSTotal Voting Rights
27th Sep 20077:01 amRNSBoard Changes
21st Sep 200711:31 amRNSAdditional Listing
14th Sep 20072:42 pmRNSHolding in US Operation
6th Sep 200710:36 amRNSAGM Statement
15th Aug 20074:39 pmRNSAIM Rule 26
15th Aug 20078:00 amRNSChange of Adviser
24th Jul 20077:00 amRNSFinal Results
16th Jul 20072:41 pmRNSNotice of Results
10th Jul 20074:02 pmRNSNotice of Results
4th May 20077:01 amRNSDirector Shareholding
3rd May 200711:44 amRNSMarketing Spend Q1 07
3rd May 20079:58 amRNSHolding(s) in Company
2nd May 200711:55 amRNSGrant of Share Options
30th Apr 20077:03 amRNSSecond Interim Results
18th Apr 20077:01 amRNSBoard Appointment
10th Apr 20073:44 pmRNSNotice of Results
21st Mar 20073:01 pmRNSHolding(s) in Company
21st Mar 20072:57 pmRNSHolding(s) in Company
21st Mar 20072:44 pmRNSHolding(s) in Company
8th Mar 20077:01 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.